Visceral adiposity, genetic susceptibility, and risk of complications among individuals with Crohn's disease

Inflammatory Bowel Diseases

Volumn 23, Issue 1, 2017, Pages 82-88

  Van Der Sloot, Kimberley W J ^a,b   Joshi, Amit D ^a   Bellavance, Danielle R ^a   Gilpin, Katherine K ^a   Stewart, Kathleen O ^c   Lochhead, Paul ^a   Garber, John J ^a   Giallourakis, Cosmas ^a   Yajnik, Vijay ^a   Ananthakrishnan, Ashwin N ^a   Alizadeh, Behrooz Z ^b   Xavier, Ramnik J ^a   Khalili, Hamed ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Dartmouth Hitchcock Medical School   (United States)

Author keywords

Crohn's disease complications; genetic predisposition; obesity; visceral adipose tissue

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; INTESTINE SURGERY; INTRAPERITONEAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; GENETICS; INTRA-ABDOMINAL FAT; MASSACHUSETTS; ODDS RATIO; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REGISTER; STATISTICAL MODEL; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ADULT; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRA-ABDOMINAL FAT; LOGISTIC MODELS; MALE; MASSACHUSETTS; ODDS RATIO; PROSPECTIVE STUDIES; REGISTRIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84997832042     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000978     Document Type: Article

References (42)

1. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, et al. The natural history of adult crohn?s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289-297.
2. Solberg IC, Vatn MH, Hoie O, et al. Clinical course in crohn?s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430-1438.
3. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6:339-346.
4. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205-217.
5. Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in asiapacific. Gut. 2015;64:1063-1071.
6. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.
7. Moreno-Navarrete JM, Sabater M, Ortega F, et al. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-Associated insulin resistance. PLoS One. 2012;7:e37160.
8. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484.
9. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444: 1027-1031.
10. Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070-11075.
11. Khalili H, Ananthakrishnan AN, Konijeti GG, et al. Measures of obesity and risk of crohn?s disease and ulcerative colitis. Inflamm Bowel Dis. 2015;21:361-368.
12. Pringle PL, Stewart KO, Peloquin JM, et al. Body mass index, genetic susceptibility, and risk of complications among individuals with crohn?s disease. Inflamm Bowel Dis. 2015;21:2304-2310.
13. Fink C, Karagiannides I, Bakirtzi K, et al. Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm Bowel Dis. 2012;18:1550-1557.
14. Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in crohn?s disease. Gastroenterology. 1999;117:73-81.
15. Schaffler A, Furst A, Buchler C, et al. Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in crohn?s disease: regulation by steroid treatment. J Gastroenterol Hepatol. 2006;21:1412-1418.
16. Erhayiem B, Dhingsa R, Hawkey CJ, et al. Ratio of visceral to subcutaneous fat area is a biomarker of complicated crohn?s disease. Clin Gastroenterol Hepatol. 2011;9:684-687.e1.
17. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847-850.
18. Uko V, Vortia E, Achkar JP, et al. Impact of abdominal visceral adipose tissue on disease outcome in pediatric crohn?s disease. Inflamm Bowel Dis. 2014;20:2286-2291.
19. Buning C, von Kraft C, Hermsdorf M, et al. Visceral adipose tissue in patients with crohn?s disease correlates with disease activity, inflammatory markers, and outcome. Inflamm Bowel Dis. 2015;21:2590-2597.
20. Connelly TM, Juza RM, Sangster W, et al. Volumetric fat ratio and not body mass index is predictive of ileocolectomy outcomes in crohn?s disease patients. Dig Surg. 2014;31:219-224.
21. Li Y, Zhu W, Gong J, et al. Visceral fat area is associated with a high risk for early postoperative recurrence in crohn?s disease. Colorectal Dis. 2015;17:225-234.
22. Cleynen I, Boucher G, Jostins L, et al. Inherited determinants of crohn?s disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387:156-167.
23. Halfvarson J, Bodin L, Tysk C, et al. Inflammatory bowel disease in a swedish twin cohort: a long-Term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124:1767-1773.
24. Klopfenstein BJ, Kim MS, Krisky CM, et al. Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans. Br J Radiol. 2012;85:e826-830.
25. Blitman NM, Baron LS, Berkenblit RG, et al. Feasibility of using singleslice MDCT to evaluate visceral abdominal fat in an urban pediatric population. AJR Am J Roentgenol. 2011;197:482-487.
26. Qi Q, Chu AY, Kang JH, et al. Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med. 2012;367:1387-1396.
27. Li S, Zhao JH, Luan J, et al. Physical activity attenuates the genetic predisposition to obesity in 20, 000 men and women from EPIC-norfolk prospective population study. PLoS Med. 2010;7:e1000332.
28. Ananthakrishnan AN, Huang H, Nguyen DD, et al. Differential effect of genetic burden on disease phenotypes in crohn?s disease and ulcerative colitis: analysis of a north american cohort. Am J Gastroenterol. 2014;109:395-400.
29. Schaffler A, Scholmerich J, Salzberger B. Adipose tissue as an immunological organ: toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol. 2007;28:393-399.
30. La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol. 2004;4:371-379.
31. Bertin B, Desreumaux P, Dubuquoy L. Obesity, visceral fat and crohn?s disease. Curr Opin Clin Nutr Metab Care. 2010;13:574-580.
32. Filkova M, Haluzik M, Gay S, et al. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133:157-170.
33. Fontana L, Eagon JC, Trujillo ME, et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010-1013.
34. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92:347-355.
35. Preis SR, Massaro JM, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the framingham heart study. Obesity (Silver Spring). 2010;18:2191-2198.
36. Bjorndal B, Burri L, Staalesen V, et al. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes. 2011;2011:490650.
37. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the framingham heart study. Circulation. 2007;116:39-48.
38. Nicklas BJ, Penninx BW, Cesari M, et al. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the health, aging and body composition study. Am J Epidemiol. 2004;160:741-749.
39. Ghigliotti G, Barisione C, Garibaldi S, et al. Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. Inflammation. 2014;37:1337-1353.
40. Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in crohn?s disease. Gut. 2012;61:78-85.
41. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
42. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363: 2211-2219.